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Occult Fallopian Tube Carcinoma
Detected in Routine Pelvic
Washing Specimens Submitted
for Staging:
Another Justification for Pelvic
Washing Cytology?
Julie M. Jorns, M.D.* and Stewart M. Knoepp, M.D., Ph.D.
Peritoneal washing cytology is important in the staging, progno-
sis, and treatment schema for women diagnosed with gyneco-
logic malignancies. Additionally, peritoneal washings are often
performed before the specific diagnosis or even the distinction
between benign or malignant lesion is known. Occasionally, the
cytology and surgical pathology specimens, although obtained
during the same procedure, will show unexpected and/or dis-
cordant findings. Perhaps, the greatest dilemma occurs when
atypical cells suggestive of malignancy are identified in perito-
neal washing specimens when a corresponding benign or dis-
cordantly low grade malignant diagnosis is made in the surgical
pathology specimen. We present two such cases in which further
investigation proved extremely valuable, not only leading to re-
solution of initially discrepant cytologic and surgical pathology
findings but also in the process leading to second diagnoses of
early fallopian tube carcinoma. Increasing evidence appears to
be pointing to the fallopian tube as the site of origin of many se-
rous carcinomas previously thought to be of primary pelvic or
ovarian origin. These cases further confirm the utility of perito-
neal washing cytology as a diagnostic modality when routine
gross examination and sampling of the surgical specimens alone
would have failed to provide the complete diagnosis. Diagn.
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The practice of performing peritoneal washing cytology in
cases of suspected gynecologic malignancy was introduced
by Keetal and Elkins in 1965 in attempts to detect early
cancer spread1 and was subsequently shown to have signifi-
cant prognostic implications.2 This led to widespread ac-
ceptance and utilization with incorporation into the Interna-
tional Federation of Gynecology and Obstetrics (FIGO)
staging classification of ovarian neoplasms in 1975, and en-
dometrial carcinomas in 1989, and is still the foundation by
which women get stratified into different treatment
approaches. This is likely the reason that many institutions
have a policy of performing peritoneal washing cytology in
the vast majority of gynecologic surgeries, both benign and
malignant, whether a preoperative diagnosis has been made
or not. Occasionally, however, cytology may show unex-
pected findings. We present two such cases in which perito-
neal washing cytology results conflicted with those of the
surgical pathology examination, which posed a significant
diagnostic dilemma. However, both cases also demonstrate
how further investigation helped to resolve this dilemma
and further confirm the utility of peritoneal washing cytol-
ogy in the diagnosis of gynecologic malignancies.
Case 1
A 78-year-old gravida 4, para 4 postmenopausal female pre-
sented to her primary care physician complaining of hema-
turia. An extensive urologic work-up including urine cytol-
ogy, cystoscopy with bladder biopsies, and retrograde pye-
logram was negative. However, she later noted a pink
vaginal discharge and a pelvic ultrasound revealed a
slightly thickened endometrial stripe (4 mm). She subse-
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quently underwent endometrial biopsy which showed well-
differentiated endometrial adenocarcinoma, endometrioid
type, preliminarily FIGO grade 1. She was deemed to have
clinical stage 1 endometrial adenocarcinoma and underwent
Da Vinci-assisted total laparoscopic hysterectomy (LH),
bilateral salpingo-oopherectomy, bilateral pelvic, obturator,
and periaortic lymphadenectomy, and pelvic washings.
The main surgical resection specimen demonstrated a
3.2 3 2.5 3 0.7 cm grossly myoinvasive white-tan tumor
involving the posterior uterus and portion of the anterior
uterus without involvement of the lower uterine segment
or cervix. Histologic examination revealed a well-differen-
tiated but complex glandular architecture with areas of
confluence and associated desmoplastic stroma. The glands
showed enlarged, multilayered epithelial cells with
clumped chromatin, prominent nucleoli and interspersed
mitotic figures (Fig. 1). Neither a significant solid compo-
nent nor areas of divergent differentiation were identified.
These features were diagnostic for a FIGO grade 1 endo-
metrioid endometrial adenocarcinoma, and consistent with
the prior diagnosis made from a curettage specimen. The
tumor displayed myoinvasion into the inner half of the
myometrium (0.4 cm maximum invasion/1.3 cm total uter-
ine thickness), and no true angiolymphatic invasion was
identified. Interestingly, pseudo-vascular space involve-
ment (VSI) was seen in large, thick-walled ectatic vessels
in the outer myometrium. This phenomenon was recently
described by Kithara et al.,3 and consists of artificially
detached fragments of friable tumor that become embed-
ded in myometrial spaces during grossing procedures. It is
more commonly seen in mechanically manipulated LH
specimens, and tumor foci lack features of true VSI such
as adherence to the vessel walls, tumor molding in the
shape of the associated vessel, and/or tumor thrombi.
Nevertheless, the findings provided an additional source of
consideration for origin of the atypical cells (discussed
below) seen in the pelvic washing. The recognition of such
detached tumor fragments in lymphovascular spaces as
artifactual is important in preventing overtreatment of
patients with otherwise low-grade, low-stage tumors. Addi-
tional findings included medial calcific atherosclerosis of
uterine arterioles, benign paratubal cysts, bilaterally, unre-
markable ovaries, and mild reactive atypia of bilateral fal-
lopian tubes. A total of 37 lymph nodes were identified, all
of which were negative for malignancy. On the basis of the
surgical/pathologic findings, the patient’s endometrial ade-
nocarcinoma was designated as stage IB.
Despite the relatively favorable diagnosis, concurrent
peritoneal washing cytology showed the liquid-based prep-
arations to contain scattered highly atypical cells with high
nuclear:cytoplasmic (N:C) ratio, coarse chromatin, and
prominent nucleoli (Fig. 2). These cells were scant in the
cell block and thus could not be further classified via im-
munohistochemical staining. Also, present within both the
liquid-based and cell block specimens were scattered be-
nign-appearing tubal epithelial cells, some of which dis-
played a spectrum of reactive atypia (Fig. 3). The apparent
disparity between the findings seen in the surgical pathol-
ogy and cytology specimens posed a significant diagnostic
dilemma, especially due to the scant nature of the malig-
nant-appearing cells within the pelvic washings. Because
of this, the surgical specimen was re-examined and
although no other significant gross findings were identified
the fallopian tubes were submitted entirely for histologic
evaluation, revealing a 0.3 cm focus of high-grade serous
carcinoma with cytologic features identical to that of the
scattered malignant cells seen in the pelvic washings
(Fig. 4). The carcinoma appeared to arise in the fimbriated
end of the fallopian tube and in direct association with in
situ carcinoma, which was highlighted by p53 immunohis-
tochemical staining. Thus, the patient was given the second
diagnosis of a high risk stage 1 fallopian tube carcinoma
(stage 1c with tumor confined to the tube but with positive
pelvic washings). Completion staging including omentec-
tomy, peritoneal biopsies, and bilateral diaphragm scrap-
ings was negative. At the time of this report she had just
began the first of four planned cycles with Carboplatin and
Taxol chemotherapy.
Case 2
A 66-year-old gravida 3, para 3, postmenopausal female
presented to the University of Michigan alternative hyster-
ectomy clinic for second opinion for treatment of her ‘‘fi-
broid uterus.’’ She had brought a copy of a pelvic ultra-
sound from 1999, which demonstrated a 7 cm solid mass
posterior to the uterus. The patient then underwent a pel-
vic Magnetic Resonance Imaging (MRI) which revealed a
20 3 12 cm solid mass with focal degenerative changes
located posterior to the uterus without clear identification
of the organ of origin. The patient consented to have the
mass resected but desired removal of the least amount of
tissue possible only. At the time of surgery, the mass was
found to arise from the left ovary with grossly unremark-
able uterus and right adnexa. Unilateral oopherectomy
with partial salpingectomy was performed.
The surgical resection specimen consisted of a 1.55 kg,
22 3 14 3 9.5 cm ovary completely replaced by a pre-
dominantly firm, white, fibrous tumor with foci of yellow
coloration and cystic change and an attached 8 cm portion
of adhesed fallopian tube. Microscopic examination
revealed the tumor to consist predominantly of intersect-
ing bundles of banal spindle cells and dense hyaline
bands with interspersed edematous regions containing
hyaline droplets (Fig. 5). The minority of the tumor which
corresponded to the grossly yellow areas was slightly
more cellular with banal, plump ovoid cells, which
stained positive for oil-red-O and weakly for inhibin-a.
There was no cytologic atypia and mitoses were not iden-
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tified. A reticulin stain showed characteristic encircling of
the individual tumor cells. On the basis of these findings,
the patient was diagnosed with fibrothecoma.
Despite the apparent benign diagnosis, concurrent pel-
vic washings showed three-dimensional clusters of highly
atypical cells with increased N:C ratio, coarse chromatin
and prominent nucleoli (Fig. 6, Top Panel). These cells
were also prominent in the cell block in which they also
displayed intracytoplasmic vacuoles and lumen formation,
findings all consistent with adenocarcinoma (Fig. 6, Bot-
tom Panel). This disparity led to further investigation
including review of the surgical pathology slides and im-
munohistochemical staining of the cell block. Upon
review, a single slide of fallopian tube revealed mild
cytologic atypia, thus the remainder of the fallopian tube
was submitted for histologic evaluation and deeper sec-
tions and immunohistochemical stains were performed on
this tissue block. None of the additional sections of fallo-
pian tube revealed foci of atypia; however, deeper sec-
tions of the slide with fallopian tube atypia revealed loss
of normal epithelial stratification, large, hyperchromatic
cells with increased N:C ratio and prominent nucleoli and
interspersed mitotic figures, consistent with intraepithelial
carcinoma (Fig. 7). These cells showed strong p53 expres-
sion and an increased proliferation index via Mib-1 (ki-
67) immunohistochemical staining. Immunostains per-
formed on the pelvic washing cell block showed positive
staining of the malignant cells with cytokeratin 7, epithe-
Fig. 3. Case 1: Pelvic washing cytology with tubal epithelial cells dis-
playing a spectrum of reactive atypia. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
Fig. 4. Case 1: Fallopian tube with high-grade serous carcinoma. [Color
figure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
Fig. 1. Case 1: Well-differentiated endometrial adenocarcinoma, endo-
metrioid type. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
Fig. 2. Case 1: Pelvic washing cytology with highly atypical cells.
[Color figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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lial membrane antigen (EMA), Ber-EP4, and p53 and no
staining with CEA or calretinin, an immunophenotype
consistent with serous carcinoma. It was recommended
that the patient undergo completion staging and possible
chemotherapy but the patient declined, stating she was
going to seek a second opinion. No further follow-up in-
formation was available at the time of this report.
Discussion
Peritoneal washing cytology is an important and accepted
diagnostic procedure in the staging of ovarian and endo-
metrial neoplasms. Many studies have examined the sen-
sitivity of peritoneal washings and have shown variable
results, with sensitivities ranging from as low as 50.7% to
as high as 88%.4–7 This range likely reflects a variety of
factors from clinical aspects such as organ of tumor ori-
gin, extent of peritoneal involvement, and histologic sub-
type to technical factors involved in the acquisition and
preparation of the cytology specimen. Differences in
study design and especially in selection criteria also affect
sensitivity, with higher numbers seen in studies selecting
for only those cases with histologically-proven disease.4
In contrast to the moderate sensitivity seen in pelvic
washing specimens, the specificity of peritoneal washings
is excellent ( 98%), especially with biopsy confirmed
intra-peritoneal cancer involvement.4 Occasional false pos-
itives have been well-documented, however, most notably
in cases of endometriosis, endosalpingiosis, and reactive
mesothelial atypia.8–10 The combination of both cytomor-
phologic findings, including the specimen background
appearance, along with the clinical history is often suffi-
cient to make the distinction from carcinoma. More specifi-
cally, the presence of both glandular and stromal cells with
background hemosiderin-laden macrophages would point
to the benign diagnosis of endometriosis as would the pres-
ence of ciliated cells in endosalpingiosis. Reactive meso-
thelial cells can form tight clusters with nuclear features
that may mimic borderline or low grade ovarian carcino-
mas, especially when psammoma bodies are also present.
Immunohistochemical stains can serve as an important
Fig. 6. Case 2: Pelvic washing cytology with highly atypical cell clus-
ters in liquid-based preparations (top panel) and cell block (bottom
panel). [Color figure can be viewed in the online issue, which is avail-
able at www.interscience.wiley.com.]
Fig. 7. Case 2: Fallopian tube carcinoma in situ. [Color figure can be
viewed in the online issue, which is available at www.interscience.
wiley.com.]Fig. 5. Case 2: Ovarian fibrothecoma. [Color figure can be viewed in
the online issue, which is available at www.interscience.wiley.com.]
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adjunct in these cases that prove more challenging when
differentiating between reactive mesothelial proliferations
and adenocarcinoma, given that the cell block contains an
adequate representation of the atypical cells.11,12
Despite the need to be cautious of these potential pitfalls
most positive peritoneal washings are indicative of perito-
neal involvement by the patient’s known gynecologic
malignancy. Up-staging of the neoplasm may be based
solely upon peritoneal washing cytology, with prognostic
implications and specific staging dependent on the organ
of origin. In these cases, a positive peritoneal washing in
patients with ovarian neoplasms have been found to dis-
play a generally poorer prognosis,5 but those with endome-
trial neoplasms appear to have little additional adverse
affect on overall outcome, despite the potentially greater
change in tumor stage.13–15 In fact, some have suggested
that the presence of endometrial carcinoma cells in perito-
neal washings of patients with low clinical stage disease
are transient and may not be capable of metastatic growth
and instead of representing intra-peritoneal spread likely
are the result of surgical manipulation or prior hysteros-
copy.16,17 Because of this there has some debate about the
utility of peritoneal washings in clinically early stage endo-
metrial carcinoma. These patients designated as surgical
stage IIIA disease based on pelvic washings alone will also
have similarly favorable outcomes with or without adju-
vant treatment, thus its use is also controversial.17 Given
these data, our findings are especially important because
they provide an additional benefit to pelvic washing cytol-
ogy (i.e., the initial identification of a tubal carcinoma may
result from a positive pelvic washing cytology).
At first glance, case 1 appeared to be such a case in
which the scattered atypical cells could represent dissemi-
nation of endometrial carcinoma in the peritoneal cavity,
which may or may not have influenced further prognosis
and therapy. These atypical cells were scant and accom-
panied by a significant population of reactive-appearing
ciliated cells resembling fallopian tube epithelium, raising
the question that this could be a reactive but benign pro-
cess. However, the degree of atypia was higher than that
seen in the patient’s well-differentiated endometrial carci-
noma, and the morphology was consistent with a serous
tumor, raising the suspicion of a second occult malig-
nancy. Further investigation with immunohistochemical
stains could not be performed due to the paucity of atypi-
cal cells in the cell block but further evaluation of the
surgical pathology specimen revealed a small focus of
high-grade serous carcinoma of the distal fallopian tube,
finally explaining the source of these scant but malignant
cells in the peritoneal washings.
In case 2, the initial cytology and surgical pathology
diagnoses were straightforward but clearly discordant. Af-
ter ruling out error in specimen processing it was sus-
pected that this patient also had a second occult malig-
nancy. Immunohistochemical stains pointed to a serous
carcinoma and further evaluation of the fallopian tube
revealed an intraepithelial carcinoma. Despite negative
imaging studies and the lack of gross findings noted at
surgery, without completion staging we cannot speculate
on the extent of disease in the contralateral fallopian tube
and ovary or of the peritoneal cavity. Both this and the
previous case, however, illustrate how follow-up of unex-
pected findings in peritoneal washing cytology led to sec-
ond diagnoses of fallopian tube carcinoma which has sig-
nificant prognostic and treatment implications. Although
there is evidence to support a more favorable outcome
there is still little known about the prognosis of these
early fallopian tube carcinomas.18 However, based on a
surgical stage of 1C, current recommendations would
have a patient receive platinum-based systemic chemo-
therapy, which would have been unlikely to occur in case
1 and would not have even been considered in case 2.19,20
Historically, primary fallopian tube carcinomas have
been thought to be rare, making up only 0.3–1.1% of all
gynecologic malignancies and with tubal intraepithelial
carcinomas only accounting for rare cases.21 Recent evi-
dence, however, has pointed to the fallopian tube as the
source of many more high-grade serous carcinomas than
previously thought. This discovery has come about due to
the practice of prophylactic bilateral salpingo-oophorec-
tomy (BSO) in patients with BRCA1 and BRCA2 gene
mutations who have a marked increased susceptibility for
breast and ovarian cancers.22–27 Prophylactic BSO has
been shown to decrease these risks significantly, with a
96% risk reduction for ovarian carcinoma28 as well as
56% and 46% breast cancer risk reduction for BRCA1
and BRCA2 mutation carriers, respectively.29 Addition-
ally, investigators noted that a small number of these
specimens harbored occult cancers with a much higher
than expected incidence of early fallopian tube cancers.
This led to protocols designed to thinly section the ova-
ries and fallopian tubes for maximum identification of
these in situ and early invasive cancers.22–24 These rigor-
ous grossing techniques have appeared to implicate the
distal (fimbriated) end as the predominant site of tumor
origin and have led to a new model for cancer develop-
ment as described by Crum et al., which describes the
evolution from genotoxic stress leading to p53 mutations
followed by rapid progression from intra-epithelial carci-
noma to widely disseminated high-grade serous carci-
noma. Using this protocol, these investigators also exam-
ined the fallopian tubes of a small series of patients with
non-familial pelvic serous carcinomas and noted that the
majority involved the endosalpinx and more than half had
evidence of early cancer arising in the fallopian tube, sug-
gesting that it is likely the source of many high-grade se-
rous carcinomas previously thought to be primary perito-
neal in origin and is likely not limited to patients with
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increased genetic susceptibility. It has also been suggested
that many high-grade serous carcinomas classified as orig-
inating in the ovary may also be of distal fallopian tube
origin. Because of their rapid progression, these tumors
would present at higher stage in non-BRCA carriers (not
undergoing prophylactic BSO) and due to the proximity
to the ovary would more likely present as a tubo-ovarian
complex. Standard grossing techniques only include lim-
ited sampling of the fallopian tube and thus an associated
in situ component which would suggest a possible fallo-
pian tube origin could easily be missed.24,25 Similar gene
expression profiles between these serous carcinomas and
benign tubal epithelium provides further evidence to sup-
port this theory.30
The utility of peritoneal washing cytology in the identi-
fication of occult malignancy has been well-documented,
and thus, its use is recommended at the time of prophy-
lactic BSO in BRCA mutation carriers who are at greater
risk.31 Its use in presumed benign disease, however, has
been of great debate as some studies have shown its use
to be of too low utility and high cost to justify processing
of all specimens.32 However, many institutions, including
ours, perform, process, and examine peritoneal washings
in the vast majority of gynecologic surgeries, both benign
and malignant. This is frequently independent of whether
a preoperative diagnosis has been rendered. We acknowl-
edge that cost-saving measures are important in the labo-
ratory but would argue strongly that enhanced patient
care outweighs the modest additional cost with regard to
pelvic washing cytology. The cases presented herein lend
further support to an enhanced benefit/cost ratio, in that
the two patients were not known to be BRCA mutation
carriers or to have a strong family history of breast and/or
ovarian cancer but were found to have early fallopian
tube carcinomas which changed their prognosis as well as
their treatment recommendations. Although the cases we
present may be unusual and infrequent, the end result was
that for these two patients, and potentially others, this
would not have occurred without evaluation of the perito-
neal washing specimens. Additionally, these cases illus-
trate how correlation between peritoneal washing cytology
and surgical pathology findings were crucial to the dis-
covery of occult malignancy. Thus, although cytopatho-
logists must be aware of the potential pitfalls that could
lead to a false-positive diagnosis in peritoneal washing
cytology specimens, it is important to stress the utility of
further investigation and ancillary studies when faced
with discrepancies between cytology and surgical pathol-
ogy findings.
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